Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | General Medicine | Research article

Characteristics and outcomes of family-practice patients with coronavirus disease 2019: a case series

Authors: Stefania Dzieciolowska, Oumeet Ravi, Roland Grad

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

The clinical history and outcomes of coronavirus disease 2019 among people not hospitalized is not yet well characterized. To better inform clinical evaluation, we set out to characterize the natural history of coronavirus disease 2019 in primary health care.

Methods

Case series of all patients rostered to physicians at a university-affiliated Family Medicine clinic. Cases met the Centers for Disease Control and Prevention definition of coronavirus disease 2019 from March 1 to May 21 2020.

Results

In total, 89 patients meeting Centers for Disease Control and Prevention criteria for coronavirus disease 2019 were documented. Their average age was 55.6 years (range 6–95 years), and all but one was symptomatic. Fifty-seven cases (64%) had a polymerase chain reaction test for coronavirus disease 2019, of whom 77.2% tested positive. Thirty cases (33.7%) reported contact with a confirmed or probable case of coronavirus disease 2019. Based on the Charlson Comorbidity Index, 28 cases (31.5%) had no comorbid conditions. The median number of days from symptom onset to first polymerase chain reaction test was 6 days (interquartile range 2.3–11 days). The median duration of fever was 3.5 days (interquartile range 1–7 days). Twenty-four cases (27%) visited the Emergency Department, and 10 were admitted to hospital. The median number of days between symptom onset and first Emergency Department visit was 8 days (interquartile range 3.5–27 days).

Conclusions

At the start of this pandemic, the implementation of basic measures such as diagnostic testing was delayed. If we are to improve our control over the spread of coronavirus disease 2019, we will need to substantially reduce the time from symptom onset to diagnostic testing, and subsequent contact tracing. To minimize unnecessary Emergency Department visits, we propose a testable strategy for Family Medicine to engage with coronavirus disease 2019 patients in the acute phase of their illness.
Appendix
Available only for authorised users
Literature
2.
go back to reference Coronavirus disease (COVID-19) Situation Report—191 2020, World Health Organization. Coronavirus disease (COVID-19) Situation Report—191 2020, World Health Organization.
8.
go back to reference Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef
9.
go back to reference Wang A-L, Zhong X, Hurd Y. Comorbidity and sociodemographic determinants in COVID-19 mortality in an US Urban Healthcare System. medRxiv, 2020: p. 2020.06.11.20128926. Wang A-L, Zhong X, Hurd Y. Comorbidity and sociodemographic determinants in COVID-19 mortality in an US Urban Healthcare System. medRxiv, 2020: p. 2020.06.11.20128926.
10.
go back to reference Siso-Almirall A, et al. Prognostic factors in Spanish COVID-19 patients: a case series from Barcelona. PLoS ONE. 2020;15(8): e0237960.CrossRef Siso-Almirall A, et al. Prognostic factors in Spanish COVID-19 patients: a case series from Barcelona. PLoS ONE. 2020;15(8): e0237960.CrossRef
11.
go back to reference Petrilli CM, et al. Factors associated with hospitalization and critical illness among 4103 patients with COVID-19 disease in New York City. 2020, Cold Spring Harbor Laboratory. Petrilli CM, et al. Factors associated with hospitalization and critical illness among 4103 patients with COVID-19 disease in New York City. 2020, Cold Spring Harbor Laboratory.
12.
go back to reference Simonnet A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020;28(7):1195–9.CrossRef Simonnet A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020;28(7):1195–9.CrossRef
13.
go back to reference Grasselli G, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–81.CrossRef Grasselli G, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–81.CrossRef
14.
go back to reference Lavezzo E, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature. 2020;584(7821):425–9.CrossRef Lavezzo E, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature. 2020;584(7821):425–9.CrossRef
16.
go back to reference Dao TL, Hoang VT, Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis. 2021;40(1):13–25.CrossRef Dao TL, Hoang VT, Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis. 2021;40(1):13–25.CrossRef
17.
go back to reference Carrat F, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775–85.CrossRef Carrat F, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775–85.CrossRef
18.
go back to reference Punpanich W, Chotpitayasunondh T. A review on the clinical spectrum and natural history of human influenza. Int J Infect Dis. 2012;16(10):e714–23.CrossRef Punpanich W, Chotpitayasunondh T. A review on the clinical spectrum and natural history of human influenza. Int J Infect Dis. 2012;16(10):e714–23.CrossRef
19.
go back to reference McLean E, et al. Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect. 2010;138(11):1531–41.CrossRef McLean E, et al. Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect. 2010;138(11):1531–41.CrossRef
20.
go back to reference Blair PW, Brown DM, Jang M, Antar AAR, Keruly JC, Bachu VS, et al. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis. 2021;8(2). Blair PW, Brown DM, Jang M, Antar AAR, Keruly JC, Bachu VS, et al. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis. 2021;8(2).
22.
go back to reference Sun H, et al. CoVA: an acuity score for outpatient screening that predicts coronavirus disease 2019 prognosis. J Infect Dis. 2021;223(1):38–46.CrossRef Sun H, et al. CoVA: an acuity score for outpatient screening that predicts coronavirus disease 2019 prognosis. J Infect Dis. 2021;223(1):38–46.CrossRef
23.
go back to reference Shah S, et al. Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization. Acad Emerg Med. 2020;27(8):681–92.CrossRef Shah S, et al. Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization. Acad Emerg Med. 2020;27(8):681–92.CrossRef
25.
go back to reference Tu YP, et al. Swabs collected by patients or health care workers for SARS-CoV-2 testing. N Engl J Med. 2020;383(5):494–6.CrossRef Tu YP, et al. Swabs collected by patients or health care workers for SARS-CoV-2 testing. N Engl J Med. 2020;383(5):494–6.CrossRef
26.
go back to reference Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, et al. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020;180(12):1576. Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, et al. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020;180(12):1576.
Metadata
Title
Characteristics and outcomes of family-practice patients with coronavirus disease 2019: a case series
Authors
Stefania Dzieciolowska
Oumeet Ravi
Roland Grad
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-02963-7

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue